Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 May 4;2(3):e001032. doi: 10.1136/bmjopen-2012-001032

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

PMC Copyright notice

TAVI's cost-effectiveness. ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year. The x-axis indicates the operability of patients. There is an overlap between medically inoperable and high-risk operable patients. Anatomically inoperable patients are readily identifiable. For high-risk operable patients, the ICERs are very high (€750 000 per QALY). For inoperable patients, the ICER was on average €45 000 per QALY. Within the latter category, ICERs are better for anatomic inoperable patients and worse for medical inoperable patients.